Extensive Clinical Experience Remington-Davis has over 30 years of experience and has successfully completed 575 studies, demonstrating a strong track record and reliability that can be leveraged to build trust with potential clients seeking proven clinical research partners.

Patient-Centric Approach With a 98 percent patient retention rate and a database of nearly 16,000 volunteers, RDI emphasizes patient satisfaction and engagement, making it an attractive partner for sponsors focused on efficient enrollment and high participant retention.

Decentralized Trial Leadership The company's expertise in decentralized clinical trials positions it as a forward-thinking partner adapting to industry trends, appealing to sponsors looking for flexible and innovative trial solutions.

Modern Facility & Support RDI's state-of-the-art 5,000 square-foot facility and patient-friendly amenities highlight its ability to provide high-quality onsite clinical trial environments, which can be a key selling point for companies seeking reliable research sites.

Growth Opportunities With annual revenues between $10 million and $25 million and a modern tech stack, RDI offers a scalable and tech-enabled partnership opportunity. Its targeted niche in Columbus could expand through strategic collaborations with larger CROs or pharmaceutical companies seeking localized clinical trial expertise.